Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

TP53 Aberrations By FISH in CLL and Complex Karyotype at Transformation Predict for Worse Outcome in Diffuse Large B-Cell Lymphoma - Richter Transformation: A Single Institution Series of 75 DLBCL-RT Cases

Shiraz Fidai, MD, Madina Sukhanova, PhD, Brian C.-H. Chiu, PhD, Y. Lynn Lynn Wang, MD PhD, Wendy Stock, MD, Peter A Riedell, MD, Sonali M. Smith, MD, Elizabeth Hyjek, MD, Girish Venkataraman, MD MBBS

Blood (2018) 132 (Supplement 1): 2984.

https://doi.org/10.1182/blood-2018-99-112242

Published: 2018

Journal Articles

Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma

Ashraf Badros, Elizabeth Hyjek, Ning Ma, Alexander Lesokhin, Ahmet Dogan, Aaron P. Rapoport, Mehmet Kocoglu, Emily Lederer, Sunita Philip, Todd Milliron, Cameron Dell, Olga Goloubeva, Zeba Singh

Blood (2017) 130 (10): 1189–1197.

https://doi.org/10.1182/blood-2017-03-775122

Published: 2017

Includes: Supplemental data

Journal Articles

Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)

Ashraf Z Badros, MD, Elizabeth Hyjek, MD PhD, Ning Ma, Alexander M. Lesokhin, MD, Aaron P. Rapoport, MD, Mehmet H. Kocoglu, MD, Emily Lederer, RN, Sunita Philip, MBBS, Patricia Lesho, Ashlee Johnson, Cameron Dell, Olga Goloubeva, PhD, Zeba Singh, MD

Blood (2016) 128 (22): 490.

https://doi.org/10.1182/blood.V128.22.490.490

Published: 2016

Journal Articles

Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm By Using 10-Colour Flow Cytometry and Achievement of Remission By Hypercvad Therapy

Uday Deotare, MD DM, Elizabeth Hyjek, MD PhD, Anna Porwit, MDPhD, Rumina Musani, MDFCAP, FRCPC, David Barth, MD FRCPC, Emina Torlakovic, MD, Anne Tierens, MD PhD, Aaron D Schimmer, MDPhD, Andre C Schuh, MD FRCPC, Mark D. Minden, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Matthew D. Seftel, MRCP, FRCPC, MPH, Naheed Alam, MBBS,MD, Karen W.L. Yee, MDFRCPC

Blood (2014) 124 (21): 2365.

https://doi.org/10.1182/blood.V124.21.2365.2365

Published: 2014

Journal Articles

PLZF staining identifies peripheral T-cell lymphomas derived from innate-like T-cells with TRAV1-2-TRAJ33 TCR-α rearrangement

Stephanie McGregor, Anant Shah, Gordana Raca, M. Kamran Mirza, Sonali M. Smith, John Anastasi, James W. Vardiman, Elizabeth Hyjek, Sandeep Gurbuxani

Blood (2014) 123 (17): 2742–2743.

https://doi.org/10.1182/blood-2014-02-555482

Published: 2014

Journal Articles

PLZF Staining Identifies Peripheral T-Cell Lymphomas Derived From Non-Conventional T-Cells With Limited α-Chain Diversity

Stephanie McGregor, MD, PhD, Anant Shah, Gordana Raca, Kamran Mirza, MD PHD, John Anastasi, MD, James W. Vardiman, MD, Elizabeth Hyjek, MD, PhD, Sandeep Gurbuxani, MBBS, PhD

Blood (2013) 122 (21): 4300.

https://doi.org/10.1182/blood.V122.21.4300.4300

Published: 2013

Journal Articles

Targeting Angiogenesis in Mantle Cell Lymphoma: Clinical Efficacy and Correlative Studies of a Phase II Trial of RT-PEPC (Rituximab, Thalidomide and Metronomic Oral Chemotherapy with Prednisone, Etoposide, Procarbazine and Cyclophosphamide) in Relapsed/Refractory Disease.

Jia Ruan, MD, PhD, Morton Coleman, MD, Richard R. Furman, MD, Patricia Glynn, Maureen Joyce, Jamie Ketas, Ken Cheung, PhD, Sarah Church, Tsiporah Shore, MD, Eric Feldman, MD, Sarah Rutherford, Elizabeth Hyjek, MD, PhD, Amy Chadburn, MD, Shahin Rafii, MD, John P. Leonard, MD

Blood (2006) 108 (11): 2751.

https://doi.org/10.1182/blood.V108.11.2751.2751

Published: 2006

Journal Articles

Correlation of Clinical and Molecular Response to Imatinib in Polycythemia Vera (PV) Patients with Bone Marrow Morphologic and Immunophenotypic Changes.

Elizabeth Hyjek, MD, PhD, Amy Chadburn, MD, Nicholas C.P. Cross, PhD, Amy V. Jones, BSc, Su-Chieh P. Sun, MS, Susan Mathew, PhD, April Chiu, MD, April Young, MS, D.M. Knowles, MD, Richard T. Silver, MD

Blood (2006) 108 (11): 4914.

https://doi.org/10.1182/blood.V108.11.4914.4914

Published: 2006

Journal Articles

Peroxisome Proliferator-Activated Receptor Gamma Promotes the Survival of Human T Lymphoma Cells through Its Regulation of Cellular Metabolism.

Chunyan Yang, MD, PhD, Zibo Song, M.D., Seung-Hee Jo, M.S., Balazs Csernus, M.D., Ph.D., Amy Chadburn, M.D., Elizabeth Hyjek, M.D., Y. Lynn Wang, M.D., Ph.D.

Blood (2006) 108 (11): 2392.

https://doi.org/10.1182/blood.V108.11.2392.2392

Published: 2006

Journal Articles

Neither Germinal Center (GC) vs Non-Germinal Center (Non-GC) Phenotype nor FOXP1 Expression Correlate with Outcome in AIDS-Associated Diffuse Large B-Cell Lymphoma (DLBCL): Study of Patients from AIDS Malignancies Consortium Trials 010 and 034.

Amy Chadburn, MD, Xia Chen, MD PhD, April Chiu, MD, Elizabeth Hyjek, MD PhD, Wayne Tam, MD PhD, Lawrence Kaplan, MD, David T. Scadden, MD, Daniel M. Knowles, MD, Ethel Cesarman, MD PhD

Blood (2006) 108 (11): 2023.

https://doi.org/10.1182/blood.V108.11.2023.2023

Published: 2006

Journal Articles

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

April Chiu, Weifeng Xu, Bing He, Stacey R. Dillon, Jane A. Gross, Eric Sievers, Xugang Qiao, Paul Santini, Elizabeth Hyjek, Joong-won Lee, Ethel Cesarman, Amy Chadburn, Daniel M. Knowles, Andrea Cerutti

Blood (2006) 109 (2): 729–739.

https://doi.org/10.1182/blood-2006-04-015958

Published: 2006

Journal Articles

NF-κB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo

Shannon A. Keller, Denise Hernandez-Hopkins, Jelena Vider, Vladimir Ponomarev, Elizabeth Hyjek, Elaine J. Schattner, Ethel Cesarman

Blood (2006) 107 (8): 3295–3302.

https://doi.org/10.1182/blood-2005-07-2730

Published: 2006

Journal Articles

Stromal Incorporation of VEGFR-1 + , CD68 + and α-SMA + Hemangiogenic Cells Correlates with Histologic Subtype in Non-Hodgkin’s Lymphoma.

Jia Ruan, MD, PhD, Elizabeth Hyjek, MD, PhD, Andrea T. Hooper, Loic Vincent, PhD, Pouneh Kermani, PhD, Paul J. Christos, M.P.H., MS, Sherry Ikalowych, MD, Morton Coleman, MD, Barbara Hempstead, MD, PhD, John P. Leonard, MD, Amy Chadburn, MD, Shahin Rafii, MD

Blood (2005) 106 (11): 1930.

https://doi.org/10.1182/blood.V106.11.1930.1930

Published: 2005

Journal Articles

ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein

Nathalie Chevallier, Connie M. Corcoran, Christine Lennon, Elizabeth Hyjek, Amy Chadburn, Vivian J. Bardwell, Jonathan D. Licht, Ari Melnick

Blood (2004) 103 (4): 1454–1463.

https://doi.org/10.1182/blood-2003-06-2081

Published: 2004

Journal Articles

BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus

Elizabeth Hyjek, Amy Chadburn, Yi Fang Liu, Ethel Cesarman, Daniel M. Knowles

Blood (2001) 97 (1): 270–276.

https://doi.org/10.1182/blood.V97.1.270

Published: 2001

NARROW

TP53 Aberrations By FISH in CLL and Complex Karyotype at Transformation Predict for Worse Outcome in Diffuse Large B-Cell Lymphoma - Richter Transformation: A Single Institution Series of 75 DLBCL-RT Cases

Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma

Pembrolizumab in Combination with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM)

Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm By Using 10-Colour Flow Cytometry and Achievement of Remission By Hypercvad Therapy

PLZF staining identifies peripheral T-cell lymphomas derived from innate-like T-cells with TRAV1-2-TRAJ33 TCR-α rearrangement

PLZF Staining Identifies Peripheral T-Cell Lymphomas Derived From Non-Conventional T-Cells With Limited α-Chain Diversity

Targeting Angiogenesis in Mantle Cell Lymphoma: Clinical Efficacy and Correlative Studies of a Phase II Trial of RT-PEPC (Rituximab, Thalidomide and Metronomic Oral Chemotherapy with Prednisone, Etoposide, Procarbazine and Cyclophosphamide) in Relapsed/Refractory Disease.

Correlation of Clinical and Molecular Response to Imatinib in Polycythemia Vera (PV) Patients with Bone Marrow Morphologic and Immunophenotypic Changes.

Peroxisome Proliferator-Activated Receptor Gamma Promotes the Survival of Human T Lymphoma Cells through Its Regulation of Cellular Metabolism.

Neither Germinal Center (GC) vs Non-Germinal Center (Non-GC) Phenotype nor FOXP1 Expression Correlate with Outcome in AIDS-Associated Diffuse Large B-Cell Lymphoma (DLBCL): Study of Patients from AIDS Malignancies Consortium Trials 010 and 034.

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

NF-κB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo

Stromal Incorporation of VEGFR-1 + , CD68 + and α-SMA + Hemangiogenic Cells Correlates with Histologic Subtype in Non-Hodgkin’s Lymphoma.

ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein

BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only